𝔖 Bobbio Scriptorium

✦ LIBER ✦

Review: In patients with heart failure, β-blockers reduce mortality but do not differ from each other

✍ Scribed by Khazanie, Prateeti; Newby, L. Kristin

Book ID: 120711836
Publisher: American College of Physicians
Year: 2013
Tongue: English
Weight: 221 KB
Volume: 158
Category: Article
ISSN: 0003-4819
DOI: 10.7326/0003-4819-158-10-201305210-02002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Review finds combining angiotensin recep

Review finds combining angiotensin receptor blockers with ACE inhibitors in heart failure may only benefit people with contraindications to β blockers: Abstracted from: Dimopoulos K, Salukhe TV, Coats AJ, et al. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker). Int J Cardiol 2004; 93(2–3): 105–11.

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Trial finds candesartan reduces cardiova

Trial finds candesartan reduces cardiovascular deaths and hospital admissions in people with heart failure, but may not affect all cause mortality: Abstracted from: Pfeffer MA, Swedberg K, Granger CB, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003; 362(9386): 759–66

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 134 KB